KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $527.5 million.

  • Aurinia Pharmaceuticals' Liabilities and Shareholders Equity fell 397.43% to $527.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 243.27%. This contributed to the annual value of $550.6 million for FY2024, which is 47.13% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Liabilities and Shareholders Equity of $527.5 million as of Q3 2025, which was down 397.43% from $502.6 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Liabilities and Shareholders Equity high stood at $555.0 million for Q3 2023, and its period low was $360.1 million during Q3 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $496.5 million, with a median of $506.9 million in 2022.
  • Examining YoY changes over the last 5 years, Aurinia Pharmaceuticals' Liabilities and Shareholders Equity showed a top increase of 4000.75% in 2021 and a maximum decrease of 2202.14% in 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' Liabilities and Shareholders Equity (Quarter) stood at $543.4 million in 2021, then decreased by 13.34% to $470.9 million in 2022, then rose by 16.4% to $548.1 million in 2023, then grew by 0.47% to $550.6 million in 2024, then fell by 4.2% to $527.5 million in 2025.
  • Its last three reported values are $527.5 million in Q3 2025, $502.6 million for Q2 2025, and $504.8 million during Q1 2025.